Copaxone and Gemfibrozil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Copaxone (glatiramer acetate) and Gemfibrozil (gemfibrozil). Common drug interactions include white blood cell count decreased among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Copaxone and Gemfibrozil. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Copaxone?

Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. eHealthMe is studying from 56,931 Copaxone users. Check the latest studies of Copaxone.

What is Gemfibrozil?

Gemfibrozil has active ingredients of gemfibrozil. It is often used in high blood cholesterol. eHealthMe is studying from 18,213 Gemfibrozil users. Check the latest studies of Gemfibrozil.

On Jul, 18, 2026

33 people who take Copaxone and Gemfibrozil together, and have interactions are studied.

Copaxone and Gemfibrozil drug interactions.

What are the common drug interactions of Copaxone and Gemfibrozil, by gender? *:

female:

White blood cell count decreased
Asthenia (weakness)
Anxiety
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Fall
Fear
Gait disturbance
Injection site reaction
Injection site urticaria (rash of round, red welts on the skin at injection site)

male:

Arthralgia (joint pain)
Back injury
Immediate post-injection reaction
Influenza like illness
Lipoma (a growth of fatty tissue that slowly develops just under your skin)
Memory impairment
Muscular weakness (muscle weakness)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Pain in extremity
Pyrexia (fever)

What are the common drug interactions of Copaxone and Gemfibrozil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Immediate post-injection reaction

40-49:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Influenza like illness
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

50-59:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Basedow's disease (autoimmune disease where the thyroid is overactive, producing an excessive amount of thyroid hormones)
Breast cancer
Death
Depression
Drug ineffective
Emotional distress
Fear
Hyperlipidaemia (presence of excess lipids in the blood)

60+:

Asthenia (weakness)
Drug ineffective
Contusion (a type of hematoma of tissue in which capillaries)
Cough
Dyspnoea (difficult or laboured respiration)
Ewing's sarcoma (malignant small, round, blue cell tumour)
Fear
Hospitalisation
Hypokalaemia (low potassium)
Injection site pain

What are the existing conditions these people have? *

Gait Disturbance: 6 people, 18.18%
Pain: 4 people, 12.12%
Thyroid Diseases: 2 people, 6.06%
Quit Smoking: 2 people, 6.06%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 6.06%
High Blood Pressure: 2 people, 6.06%
Depression: 2 people, 6.06%
Bladder Disorder: 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Copaxone and Gemfibrozil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously